Search Results - "Guo, Zhaoji"

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers by Tao, Zhonghua, Liu, Jianxia, Li, Ting, Xu, Hong, Chen, Kai, Zhang, Jian, Zhou, Hao, Sun, Jie, Han, Jinming, Guo, Zhaoji, Yang, Hua, Cao, Wen-Ming, Hu, Xichun

“…Receptor tyrosine kinases (RTKs) are a class of tyrosine kinases that regulate cell-to-cell communication and control a variety of complex biological…”
Get full text

Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer by Yuan, Renshun, Wang, Gang, Xu, Zhihua, Zhao, Hong, Chen, Huabin, Han, Ye, Wang, Bin, Zhou, Jin, Hu, Hao, Guo, Zhaoji, Shen, Hugang, Xue, Xiaofeng

“…Previous studies suggested that abnormal miRNA expression was a significant characteristic of malignant tumors. We aimed to explore the role of miR-106a as the…”
Get more information

Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer by Lu, Qingfu, Guo, Zhaoji, Qian, Haixin

“…In China, breast cancer is the most commonly occurring cancer in women. MicroRNAs (miRs) are a group of endogenous small non-coding RNAs, which serve a role in…”
Get full text

Abstract P2-01-07: Combination of pyrotinib with trastuzumab, taxanes and platinum as neoadjuvant therapy in patients with HER2-positive early or locally advanced breast cancer: a multicenter phase II trial by Zhou, Hao, Wang, Lei, Wang, Lei, Guo, Zhaoji

“…Abstract Background: Pyrotinib (an irreversible pan-ErbB inhibitor) plus capecitabine have shown clinically and statistically meaningful progression-free…”
Get full text

Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years by Zhou, Hao, Lv, Qingfu, Guo, Zhaoji

“…Tamoxifen is the most commonly used drug to treat estrogen receptor positive (ER+) breast cancer. However, many patients with ER+ breast cancer have…”
Get full text

A promising gene delivery system developed from PEGylated MoS2 nanosheets for gene therapy by Kou, Zhongyang, Wang, Xin, Yuan, Renshun, Chen, Huabin, Zhi, Qiaoming, Gao, Ling, Wang, Bin, Guo, Zhaoji, Xue, Xiaofeng, Cao, Wei, Guo, Liang

“…A new class of two-dimensional (2D) nanomaterial, transition metal dichalcogenides (TMDCs) such as MoS 2 , MoSe 2 , WS 2 , and WSe 2 which have fantastic…”
Get full text

MiR-638 acts as a tumor suppressor gene in gastric cancer by Shen, Yu, Chen, Haiqun, Gao, Ling, Zhang, Weigang, He, Jun, Yang, Xiaohua, Qin, Lei, Xue, Xiaofeng, Guo, Zhaoji

“…Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying…”
Get full text

Abstract PS10-43: Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real world study by Feng, Jifeng, Zhang, Lili, Guo, Zhaoji, Zhou, Jun, Zhu, Mingzhen, Wu, Xiaohong, Yi, Tongbo, Guo, Yujiang, Li, Xiaoqin, Yu, Hao, Mao, Weidong, Gu, Bei, Han, Zhengxiang, Zuo, Yun, Liu, Yanhua, Wang, Xufen

“…Abstract Backgrounds: Pyrotinib (an irreversible pan-ErbB receptor tyrosine kinase inhibitor) plus capecitabine have been approved for patients with advanced…”
Get full text

Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma by Yuan, Renshun, Zhi, Qiaoming, Zhao, Hong, Han, Ye, Gao, Ling, Wang, Bin, Kou, Zhongyang, Guo, Zhaoji, He, Songbing, Xue, Xiaofeng, Hu, Hao

“…Aberrant microRNA (miRNA) expression has been widely recognized to play an extremely important role in several cancers, including hepatocellular carcinoma…”
Get full text